PMID: 11923637Mar 30, 2002Paper

Treating patients with psychogenic non-epileptic seizures

Current Opinion in Neurology
Markus Reuber, Allan O House

Abstract

While the diagnostic features of psychogenic non-epileptic seizures have been better characterized in recent years, comparatively little is written about management. This review provides guidance to clinicians involved in the treatment of patients with psychogenic non-epileptic seizures and generates ideas for future research. It summarizes the recent literature specifically dealing with the treatment of such seizures and draws on the wider psychiatric literature on effective treatments for patients with other medically unexplained symptoms.

References

May 29, 1986·The New England Journal of Medicine·G R SmithD C Ray
Jan 1, 1982·Neurology·D W KingL C Ward
Nov 1, 1995·Epilepsia·T S WalczakA Notarfrancesco
Apr 1, 1995·Current Opinion in Neurology·J French
Jun 1, 1995·Seizure : the Journal of the British Epilepsy Association·J KuykR van Dyck
Jan 1, 1996·The American Journal of Psychiatry·E S Bowman, O N Markand
Jun 1, 1996·Neurology·R P Lesser
Mar 31, 1998·BMJ : British Medical Journal·H L CrimliskM A Ron
May 19, 1998·Psychosomatics·J L GriffithM E Griffith
Jul 22, 1998·Epilepsia·K R Sigurdardottir, E Olafsson
Sep 17, 1998·Epilepsia·L E WestbrookR Geocadin
Nov 10, 1998·Seizure : the Journal of the British Epilepsy Association·R C MartinR Kuzniecky
Dec 3, 1998·Journal of Psychosomatic Research·P Coia, S Morley
Mar 23, 1999·Archives of Pediatrics & Adolescent Medicine·E WyllieB Wolgamuth
Jun 8, 1999·Psychiatry Research·D Kalogjera-Sackellares, J C Sackellares
Jul 6, 2000·Seizure : the Journal of the British Epilepsy Association·S R Benbadis, W Allen Hauser
Aug 17, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·R J Brown, M R Trimble
Nov 10, 2000·Lancet·M ReuberM Sadler
Feb 17, 2001·BMJ : British Medical Journal·S M GilbodyT A Sheldon
Feb 24, 2001·The Journal of Nervous and Mental Disease·P KrawetzJ Maher
Jul 14, 2001·BMJ : British Medical Journal·A F SchilteJ A Knottnerus
Jan 16, 2002·Archives of Neurology·Markus ReuberChristian E Elger
Feb 13, 2002·Neurology·M ReuberC E Elger
Mar 1, 2003·Epilepsy & Behavior : E&B·Ennapadam S. KrishnamoorthyMichael R. Trimble
Mar 1, 2003·Epilepsy & Behavior : E&B·Mark D. RuschLeeAnn Lathrop

❮ Previous
Next ❯

Citations

Mar 12, 2003·Current Treatment Options in Neurology·Stephan J. Rüegg, Marc A. Dichter
Jan 31, 2004·Epilepsy & Behavior : E&B·Anna Vinter MarquezTaoufik M Alsaadi
Jun 7, 2003·Epilepsy & Behavior : E&B·Markus Reuber, Christian E Elger
Mar 1, 2003·Epilepsy & Behavior : E&B·W Curt LaFrance, Orrin Devinsky
Oct 28, 2009·Case Reports in Medicine·Laura ScévolaSilvia Kochen
Aug 17, 2014·Epilepsy & Behavior : E&B·Katharine K McMillanW Curt LaFrance
Apr 1, 2011·Epilepsy & Behavior : E&B·Nynke M G BoddePaul A J M Boon
Nov 27, 2010·Emergency Medicine Clinics of North America·Matthew S Siket, Roland C Merchant
Oct 31, 2015·Epilepsy & Behavior : E&B·Michael SchönenbergCaroline Schell
Nov 21, 2008·Clinical Neurology and Neurosurgery·N M G BoddeA P Aldenkamp
Aug 28, 2007·Epilepsy & Behavior : E&B·Jayne L BrooksGus A Baker
May 1, 2007·Journal of Psychosomatic Research·Nynke M G BoddeAlbert P Aldenkamp
Mar 15, 2013·Epilepsia·W Curt LaFranceLaura H Goldstein
Apr 4, 2016·Seizure : the Journal of the British Epilepsy Association·Chrisma Pretorius
Feb 14, 2006·Clinical Psychology Review·Donald Sharpe, Cathy Faye
Jul 29, 2015·Seizure : the Journal of the British Epilepsy Association·Chrisma Pretorius, Melissa Sparrow
Aug 18, 2009·Seizure : the Journal of the British Epilepsy Association·N M G BoddeA P Aldenkamp
Nov 19, 2013·Epilepsy & Behavior : E&B·Gillian FaircloughRichard James Brown
Dec 4, 2012·Epilepsy & Behavior : E&B·N M G BoddeA P Aldenkamp
Oct 22, 2013·Seizure : the Journal of the British Epilepsy Association·Ioannis KarakisAndrew J Cole
Mar 13, 2012·Scottish Medical Journal·A M H Young, T B Stoker
Nov 9, 2005·Expert Review of Neurotherapeutics·Markus ReuberSteven Kemp
Feb 26, 2003·Annals of Neurology·Markus ReuberChristian Erich Elger
Oct 28, 2016·Neurology·Dirk P SaalJ Gert van Dijk

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.